DYN

Dyne Therapeutics, Inc.

Pharmaceutical Preparations · SIC 2834CIK 1818794Held by 6 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

6 managers · Q2 2026 13F

13F bookWeight

Vivo Capital

Vivo CapitalPosition history →

3.2%

—

$34.6M

$1.10B13F book · 2026-06-30

OrbiMed Advisors

OrbiMed AdvisorsPosition history →

1.4%

+10.9%

$71.9M

$5.25B13F book · 2026-06-30

Orbis Investment Management

Orbis Investment ManagementPosition history →

0.53%

+3.6%

$155.6M

$29.10B13F book · 2026-06-30

Baker Bros. Advisors

Baker Bros. AdvisorsPosition history →

0.09%

—

$18.1M

$19.96B13F book · 2026-06-30

Alps Advisors

Alps AdvisorsPosition history →

0.02%

NEW

$3.7M

$21.33B13F book · 2026-06-30

Adage Capital Management

Adage Capital ManagementPosition history →

<0.01%

(85.0%)

$3.3M

$71.32B13F book · 2026-06-30

Weight = position value ÷ the manager's total 13F long-equity value in the same filing — one definition for every row. “1st obs.” marks a position with no earlier stored 13F to compare against — it is not shown as a purchase.